Literature DB >> 21108148

Official position of the American Academy of Clinical Neuropsychology on serial neuropsychological assessments: the utility and challenges of repeat test administrations in clinical and forensic contexts.

Robert L Heilbronner1, Jerry J Sweet, Deborah K Attix, Kevin R Krull, George K Henry, Robert P Hart.   

Abstract

Serial assessments are now common in neuropsychological practice, and have a recognized value in numerous clinical and forensic settings. These assessments can aid in differential diagnosis, tracking neuropsychological strengths and weaknesses over time, and managing various neurologic and psychiatric conditions. This document provides a discussion of the benefits and challenges of serial neuropsychological testing in the context of clinical and forensic assessments. Recommendations regarding the use of repeated testing in neuropsychological practice are provided.

Entities:  

Mesh:

Year:  2010        PMID: 21108148     DOI: 10.1080/13854046.2010.526785

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  41 in total

Review 1.  Evidence-based indicators of neuropsychological change in the individual patient: relevant concepts and methods.

Authors:  Kevin Duff
Journal:  Arch Clin Neuropsychol       Date:  2012-02-29       Impact factor: 2.813

Review 2.  Clinical developmental, neuropsychological, and social-emotional features of Turner syndrome.

Authors:  Christa Hutaff-Lee; Elizabeth Bennett; Susan Howell; Nicole Tartaglia
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-02-14       Impact factor: 3.908

3.  Utility of a brief computerized battery to assess HIV-associated neurocognitive impairment in a resource-limited setting.

Authors:  Nirupama Yechoor; Sheri L Towe; Kevin R Robertson; Daniel Westreich; Noeline Nakasujja; Christina S Meade
Journal:  J Neurovirol       Date:  2016-05-31       Impact factor: 2.643

4.  Reliable change on the Boston naming test.

Authors:  Bonnie C Sachs; John A Lucas; Glenn E Smith; Robert J Ivnik; Ronald C Petersen; Neill R Graff-Radford; Otto Pedraza
Journal:  J Int Neuropsychol Soc       Date:  2012-01-23       Impact factor: 2.892

5.  Cognitive functions after spinal tap in patients with normal pressure hydrocephalus.

Authors:  H Schmidt; J Elster; I Eckert; J Wiefek; W Paulus; N von Steinbuechel; E N Abatih; J Blocher
Journal:  J Neurol       Date:  2014-09-20       Impact factor: 4.849

6.  Diffusion tensor imaging predicts cognitive function change following partial brain radiotherapy for low-grade and benign tumors.

Authors:  Christopher H Chapman; Tong Zhu; Mohamad Nazem-Zadeh; Yebin Tao; Henry A Buchtel; Christina I Tsien; Theodore S Lawrence; Yue Cao
Journal:  Radiother Oncol       Date:  2016-07-11       Impact factor: 6.280

7.  No neurocognitive advantage for immediate antiretroviral treatment in adults with greater than 500 CD4+ T-cell counts.

Authors:  Edwina J Wright; Birgit Grund; Kevin R Robertson; Lucette Cysique; Bruce J Brew; Gary L Collins; Mollie Poehlman-Roediger; Michael J Vjecha; Augusto César Penalva de Oliveira; Barbara Standridge; Cate Carey; Anchalee Avihingsanon; Eric Florence; Jens D Lundgren; Alejandro Arenas-Pinto; Nicolas J Mueller; Alan Winston; Moses S Nsubuga; Luxshimi Lal; Richard W Price
Journal:  AIDS       Date:  2018-05-15       Impact factor: 4.177

8.  Longitudinal Comparison of in Clinic and at Home Administration of the Cogstate Brief Battery and Demonstrated Practice Effects in the Mayo Clinic Study of Aging.

Authors:  N H Stricker; E S Lundt; E C Alden; S M Albertson; M M Machulda; W K Kremers; D S Knopman; R C Petersen; M M Mielke
Journal:  J Prev Alzheimers Dis       Date:  2020

Review 9.  Current best practice in the management of Turner syndrome.

Authors:  Roopa Kanakatti Shankar; Philippe F Backeljauw
Journal:  Ther Adv Endocrinol Metab       Date:  2017-12-18       Impact factor: 3.565

Review 10.  Retest effects in working memory capacity tests: A meta-analysis.

Authors:  Jana Scharfen; Katrin Jansen; Heinz Holling
Journal:  Psychon Bull Rev       Date:  2018-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.